-+ 0.00%
-+ 0.00%
-+ 0.00%
12 Health Care Stocks Moving In Monday's Intraday Session
Share
Listen to the news

Gainers

  • Venus Concept (NASDAQ:VERO) shares moved upwards by 297.2% to $5.68 during Monday's regular session. The market value of their outstanding shares is at $2.6 million.
  • INVO Fertility (NASDAQ:IVF) shares increased by 200.06% to $2.44. The company's market cap stands at $12.2 million.
  • ImmunityBio (NASDAQ:IBRX) stock rose 52.93% to $6.04. The market value of their outstanding shares is at $3.8 billion.
  • Jaguar Health (NASDAQ:JAGX) stock increased by 41.26% to $1.08. The market value of their outstanding shares is at $3.1 million.
  • Bristol-Myers Squibb Company Celegne Contingent Value Rights (NYSE:CELGR) stock rose 34.55% to $0.21.
  • PainReform (NASDAQ:PRFX) shares moved upwards by 29.41% to $1.06. The market value of their outstanding shares is at $3.2 million.

Losers

  • PAVmed (NASDAQ:PAVM) shares decreased by 28.1% to $6.29 during Monday's regular session. The market value of their outstanding shares is at $8.0 million.
  • Inspire Veterinary (NASDAQ:IVP) shares declined by 24.81% to $0.04. The market value of their outstanding shares is at $2.0 million.
  • Agape ATP (NASDAQ:ATPC) shares decreased by 23.72% to $0.08. The company's market cap stands at $5.4 million.
  • Nuwellis (NASDAQ:NUWE) stock declined by 21.52% to $1.86. The market value of their outstanding shares is at $2.1 million.
  • Prelude Therapeutics (NASDAQ:PRLD) stock fell 16.75% to $1.79. The market value of their outstanding shares is at $135.1 million.
  • Gelteq (NASDAQ:GELS) shares fell 15.33% to $1.05. The company's market cap stands at $13.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending